S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
ASX:IME

ImExHS Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.09 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive IME News and Ratings via Email

Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter.


About ImExHS

ImExHS Limited operates as an imaging software as a service and ancillary service provider in Australia and internationally. It is involved in developing and selling Hiruko software platform that comprises radiology information system, which manages the workflow management system with a patient data and image distribution system, as well as picture archiving and communication system that allows healthcare organization to capture, store, view, and share radiology images. The company was founded in 2012 and is headquartered in Mascot, Australia.

Headlines

ImExHS Limited (ASX:IME) Insider Douglas Lingard Purchases 20,000 Shares
ImExHS Limited (ASX:IME) Insider Douglas Lingard Purchases 20,000 Shares
September 10, 2021 |  americanbankingnews.com
ImExHS Limited (ASX:IME) Insider Douglas (Doug) Flynn Purchases 10,000 Shares
ImExHS Limited (ASX:IME) Insider Douglas (Doug) Flynn Purchases 10,000 Shares
September 6, 2021 |  americanbankingnews.com
Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)
Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)
August 12, 2021 |  finance.yahoo.com
ASX health stocks: 4D Medical leads after ramping up its game in the US
ASX health stocks: 4D Medical leads after ramping up its game in the US
July 25, 2021 |  msn.com
Insider Buying: The ImExHS Limited (ASX:IME) Independent Non-Executive Director Just Bought 8.7% More Shares
Insider Buying: The ImExHS Limited (ASX:IME) Independent Non-Executive Director Just Bought 8.7% More Shares
May 14, 2021 |  finance.yahoo.com
ImExHS (ASX:IME) Shareholders Booked A 30% Gain In The Last Year
ImExHS (ASX:IME) Shareholders Booked A 30% Gain In The Last Year
May 4, 2021 |  finance.yahoo.com
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
April 9, 2021 |  msn.com
ScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports near
ScoPo’s powerplays: Look to Mach7, Volpara and IMEXHS as quarterly reports near
April 2, 2021 |  msn.com
When Will ImExHS Limited (ASX:IME) Breakeven?
When Will ImExHS Limited (ASX:IME) Breakeven?
March 4, 2021 |  finance.yahoo.com
ScoPo’s health powerplays: What to look for this earnings season
ScoPo’s health powerplays: What to look for this earnings season
February 14, 2021 |  msn.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

1.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











ImExHS (ASX:IME) Frequently Asked Questions

What stocks does MarketBeat like better than ImExHS?

Wall Street analysts have given ImExHS a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ImExHS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were ImExHS's earnings last quarter?

ImExHS Limited (ASX:IME) posted its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter.
View ImExHS's earnings history.

Who are ImExHS's key executives?

ImExHS's management team includes the following people:
  • Dr. German Arango, MD, CEO & Director
  • Ms. Reena Minhas, CFO & Company Sec.
  • Mr. Andres Vanegas, Co-Founder & Strategic Accounts Mang.
  • Mr. Alejandro Varettoni, Chief Sales Officer
  • Dr. Jorge Marin, Chief Medical Officer

What is ImExHS's stock symbol?

ImExHS trades on the ASX under the ticker symbol "IME."

How much money does ImExHS make?

ImExHS has a market capitalization of $0.00 and generates $11.65 million in revenue each year.

How many employees does ImExHS have?

ImExHS employs 54 workers across the globe.

What is ImExHS's official website?

The official website for ImExHS is imexhs.com.

How can I contact ImExHS?

The company can be reached via phone at 57 1 316 4890.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.